东京热福利视频导航|日韩无码不卡一区|成人高清手机在线|在厨房乱子伦对白一区二区|中文字幕网址导航|国产原创在线亚洲黄色大片高清无码|深爱激情五月丁香亚洲综合社区|成人在线手机视频|浮力影院成人A片|日韩限制电影在线观看

Cardiology And Therapy
  • 數(shù)據(jù)庫(kù)收錄SCIE
  • 年發(fā)文量38

Cardiology And Therapy

期刊中文名:心臟病學(xué)和治療ISSN:2193-8261E-ISSN:2193-6544

該雜志國(guó)際簡(jiǎn)稱(chēng):CARDIOL THER,是由出版商Adis, Springer Healthcare出版的一本致力于發(fā)布--研究新成果的的專(zhuān)業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專(zhuān)論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。

基本信息:
期刊簡(jiǎn)稱(chēng):CARDIOL THER
是否OA:開(kāi)放
是否預(yù)警:
Gold OA文章占比:99.15%
出版信息:
出版地區(qū):United Kingdom
出版周期:4 issues per year
出版語(yǔ)言:English
出版商:Adis, Springer Healthcare
評(píng)價(jià)信息:
JCR分區(qū):Q2
影響因子:3
CiteScore:5.3
雜志介紹 JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

雜志介紹

Cardiology And Therapy雜志介紹

《Cardiology And Therapy》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊,中文名稱(chēng)心臟病學(xué)和治療,本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3,最新CiteScore 指數(shù)為5.3。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有:

  • Emerging PET Tracers in Cardiac Molecular Imaging

    Author: Singh, Shashi Bhushan; Ng, Sze Jia; Lau, Hui Chong; Khanal, Kishor; Bhattarai, Sanket; Paudyal, Pranita; Shrestha, Bimash Babu; Naseer, Rizwan; Sandhu, Simran; Gokhale, Saket; Raynor, William Y. Y.

  • Application of Single-Cell Genomics in Cardiovascular Research

    Author: Yu, Xuejing; Yang, Xianggui; Cao, Jinjin

  • Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation

    Author: Patti, Giuseppe; Wang, Rosa; Marston, Xiaocong Li; Yeh, Yu-Chen; Zimmermann, Lisa; Ye, Xin; Gao, Xin; Brueggenjuergen, Bernd

  • Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO (sic) Randomized Clinical Trial

    Author: Tan, Hong; Li, Weimin; Huang, Zhouqing; Han, Yajun; Huang, Xuecheng; Li, Dongye; Xing, Xiaochun; Monsalvo, Maria Laura; Wu, You; Mao, Jackie; Xin, Lily; Chen, Jiyan

英文介紹

Cardiology And Therapy雜志英文介紹

Cardiology And Therapy strives to be the leading publishing platform for innovative research results in the field of cardiovascular medicine. The goal of the journal is to facilitate the exchange of knowledge among medical professionals and researchers worldwide and to accelerate the development and application of cardiovascular therapies and interventions. The types of research the journal encourages range from initial basic science studies to late-stage clinical trials to long-term observational studies of patient outcomes.

Journals evaluate the safety and effectiveness of new drugs, devices or treatments at different stages. The risk factors and natural course of cardiovascular disease were explored through cohort studies and case-control studies. Use real-world data to evaluate the effectiveness of medical interventions in actual clinical practice. Focus on the patient's health status after treatment, including quality of life, functional status, and long-term prognosis. To analyze the cost-effectiveness of treatment methods for cardiovascular diseases, and to provide basis for rational allocation of medical resources.

JCR分區(qū)(2023-2024年最新版)

Cardiology And Therapy雜志 JCR分區(qū)信息

按JIF指標(biāo)學(xué)科分區(qū)
學(xué)科:CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集:ESCI
分區(qū):Q2
排名:72 / 220
百分位:

67.5%

按JCI指標(biāo)學(xué)科分區(qū)
學(xué)科:CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集:ESCI
分區(qū):Q2
排名:103 / 220
百分位:

53.41%

JCR分區(qū):JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類(lèi)按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。

CiteScore 評(píng)價(jià)數(shù)據(jù)(2024年最新版)

Cardiology And Therapy雜志CiteScore 評(píng)價(jià)數(shù)據(jù)

  • CiteScore 值:5.3
  • SJR:0.99
  • SNIP:0.915
學(xué)科類(lèi)別 分區(qū) 排名 百分位
大類(lèi):Medicine 小類(lèi):Cardiology and Cardiovascular Medicine Q2 107 / 387

72%

歷年影響因子和期刊自引率

投稿經(jīng)驗(yàn)

Cardiology And Therapy雜志投稿經(jīng)驗(yàn)

該雜志是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,該雜志在綜合專(zhuān)業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國(guó)際優(yōu)秀雜志,一般投稿過(guò)審時(shí)間都較長(zhǎng),投稿過(guò)審時(shí)間平均 6 Weeks ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢(xún)客服。

免責(zé)聲明

若用戶(hù)需要出版服務(wù),請(qǐng)聯(lián)系出版商。